Introduction and moderation of round table discussion by Franz Schubiger with panelists Catherine Longeval (Partner, Van Bael & Bellis), Michael Pitzner (Senior Legal Counsel NTO Transactions, Novartis) and Dr. Markus Wang (Partner, Bär & Karrer AG) about M&A transactions in the life sciences sector, covering legal and practical aspects with respect to a divestiture of a pharma product portfolio and a licensing and co-development agreement on the basis of case studies.
